FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
MULTICENTER TRIALS
STANDARDIZED UPTAKE VALUE
FDG
PET/CT
CELL LUNG-CANCER
UPTAKE VALUES
Medizin
610
Guidelines
Multimodal Imaging
03 medical and health sciences
POSITRON-EMISSION-TOMOGRAPHY
0302 clinical medicine
European Association of Nuclear Medicine (EANM)
Fluorodeoxyglucose F18
Imaging procedure
Quantification
1ST INTERNATIONAL WORKSHOP
Neoplasms
616
Humans
F-18-FDG PET
Tomography
Computer. Automation
Radboudumc 9: Rare cancers RIMLS: Radboud Institute for Molecular Life Sciences
UNKNOWN PRIMARY TUMORS
ROI DEFINITION
X-Ray Computed
3. Good health
Oncology
Radiology Nuclear Medicine and imaging
Positron-Emission Tomography
VOLUME MEASUREMENTS
Human medicine
Tumour
Radiopharmaceuticals
Tomography, X-Ray Computed
EMC MM-01-40-01
DOI:
10.1007/s00259-014-2961-x
Publication Date:
2014-12-01T14:26:27Z
AUTHORS (28)
ABSTRACT
Abstract
The purpose of these guidelines is to assist physicians in recommending, performing, interpreting and reporting the results of FDG PET/CT for oncological imaging of adult patients. PET is a quantitative imaging technique and therefore requires a common quality control (QC)/quality assurance (QA) procedure to maintain the accuracy and precision of quantitation. Repeatability and reproducibility are two essential requirements for any quantitative measurement and/or imaging biomarker. Repeatability relates to the uncertainty in obtaining the same result in the same patient when he or she is examined more than once on the same system. However, imaging biomarkers should also have adequate reproducibility, i.e. the ability to yield the same result in the same patient when that patient is examined on different systems and at different imaging sites. Adequate repeatability and reproducibility are essential for the clinical management of patients and the use of FDG PET/CT within multicentre trials. A common standardised imaging procedure will help promote the appropriate use of FDG PET/CT imaging and increase the value of publications and, therefore, their contribution to evidence-based medicine. Moreover, consistency in numerical values between platforms and institutes that acquire the data will potentially enhance the role of semiquantitative and quantitative image interpretation. Precision and accuracy are additionally important as FDG PET/CT is used to evaluate tumour response as well as for diagnosis, prognosis and staging. Therefore both the previous and these new guidelines specifically aim to achieve standardised uptake value harmonisation in multicentre settings.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (106)
CITATIONS (2451)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....